2025 Chinese Guideline for the Management of Cardiomyopathies
10.3969/j.issn.1000-3614.2025.05.002
- VernacularTitle:中国心肌病综合管理指南2025
- Author:
Lei SONG
;
Rutai HUI
- Collective Name:The Cardiomyopathy Specialty Alliance of National Center for Cardiovascular Diseases;Cardiovascular Precision Medicine Branch of China International Exchange and Promotive Association for Medical and Health Care
- Publication Type:Journal Article
- Keywords:
cardiomyopathy;
classification;
genetic testing;
diagnosis and treatment;
management
- From:
Chinese Circulation Journal
2025;40(5):420-462
- CountryChina
- Language:Chinese
-
Abstract:
Cardiomyopathy is a group of myocardial disorders that are clinically common and characterized by complex etiologies,heterogeneous clinical manifestations,adverse prognoses and strong associations with genetics.In recent years,significant advances and breakthroughs have been achieved in its definition,classification,precise diagnosis,and individualized treatment.This guideline integrates the latest evidence,systematically elucidates the definition,classification,etiologies and pathogenesis of various types of cardiomyopathy,and offers recommendations for diagnosis,treatment and management,with the aim to improve the clinical practice level of cardiomyopathy in China.
